Clinical Trials
- Administration of Donor T Cells With the Caspase-9 Suicide Gene
- Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies
- Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies
- Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation
- Genetic Studies of X-linked Lymphoproliferative Disease
- Immune Disorder HSCT Protocol
- Pilot Study of Unrelated Donor Hematopoietic Stem Cell Transplantation in Patients With Life Threatening Hemophagocytic Disorders
- Related Hematopoietic Stem Cell Transplantation (HSCT) for Genetic Diseases of Blood Cells
- Stem Cell Transplant for Immunologic or Histiocytic Disorders
- T-Cell Depletion and Stem Cell Transplant for Immune Deficiencies and Histiocytic Disorders
- A Clinical Assessment Study in X-Linked Myotubular Myopathy (XLMTM) Subjects
- Gene Transfer Clinical Study in X-Linked Myotubular Myopathy
- Myotubular and Centronuclear Myopathy Patient Registry
- Myotubular Myopathy Event Study
- Myotubular Myopathy Genetic Testing Study
- Prospective, Longitudinal Study of the Natural History and Functional Status of Patients With Myotubular Myopathy (MTM)
- Respiratory Muscle Function in Untreated X-Linked Myotubular Myopathy (XLMTM)
- Tamoxifen Therapy for Myotubular Myopathy
- A Novel Single Arm Phase II Study for Relapsed Germ Cell Tumours With Poor Prognosis
- A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors
- A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory Germ Cell Tumors
- A Phase II Trial Evaluating the Efficacy of Cabozantinib With Patients With Refractory GCTs
- A Pilot RCT of the PRISM Intervention for AYAs With Cancer
- A Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid Tumors
- A Study of a New Way to Treat Children With a Brain Tumor Called NGGCT
- A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
- A Study of DS-9606a in Patients With Advanced Solid Tumors
- A Study of miRNA 371 in Patients With Germ Cell Tumors
- ABT-751 in Treating Young Patients With Refractory Solid Tumors
- Accelerated v’s Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours
- Active Surveillance, Bleomycin, Carboplatin, Etoposide, or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- Adolescent and Young Adult Cancer Patients: Cognitive Toxicity on Survivorship (ACTS)
- Aerosolized Azacytidine as Epigenetic Priming for Bintrafusp Alfa-Mediated Immune Checkpoint Blockade in Patients With Unresectable Pulmonary Metastases From Sarcomas, Germ Cell Tumors, or Epithelial Malignancies
- Aflac ST0901 CHOANOME – Sirolimus in Solid Tumors
- Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
- Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell Tumors
- Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
- Auto Transplant for High Risk or Relapsed Solid or CNS Tumors
- Autologous Peripheral Blood Stem Cell Transplant for Germ Cell Tumors
- B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
- Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors
- Busulfan in Treating Children and Adolescents With Refractory CNS Cancer
- CD30 CAR for CD30+ NSGCT
- Collecting and Storing Tissue From Young Patients With Cancer
- Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
- Combination Chemotherapy in Treating Children With Newly Diagnosed Malignant Germ Cell Tumors
- Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors
- Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Germ Cell Tumors
- Combination Chemotherapy With or Without Bone Marrow or Stem Cell Transplantation in Treating Men With Untreated Germ Cell Tumors
- Computer Aided Diagnostic Tool on Computed Tomography Images for Diagnosis of Retroperitoneal Tumor in Children
- Conventional Dose Versus High Dose Sequential Chemotherapy for Poor Prognosis Germ Cell Tumors
- CpG 7909 in Treating Patients Who Have Undergone Autologous Stem Cell Transplant
- Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
- Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer
- Disulfiram and Cisplatin in Refractory TGCTs.
- Dose Intensification Study in Refractory Germ Cell Tumors With Relapse and Bad Prognosis
- Durvalumab Alone or With Tremelimumab in Refractory Germ Cell Tumors
- EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults
- EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
- Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma
- Etoposide, Carboplatin, and Bleomycin in Treating Young Patients Undergoing Surgery For Malignant Germ Cell Tumors
- Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors
- Everolimus in Refractory Testicular Germ Cell Cancer
- First Line TIP in Poor Prognosis TGCTs.
- Gemcitabine, Paclitaxel and Oxaliplatin (GemPOx)
- Genetic and Molecular Risk Profiles of Pediatric Malignant Brain Tumors in China
- Germ Cell Tumor and Testicular Tumor DNA Registry
- HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors
- High-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid Tumors
- Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
- Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Hepatocellular Carcinoma
- Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
- Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven’t Responded to Therapy
- Living After a Rare Cancer of the Ovary: Chronic Fatigue, Quality of Life and Late Effects of Chemotherapy
- Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT
- Memantine for Prevention of Cognitive Late Effects in Pediatric Patients Receiving Cranial Radiation Therapy for Localized Brain Tumors
- Molecular Epidemiology of Pediatric Germ Cell Tumors
- Molecular-Guided Therapy for Childhood Cancer
- MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors
- Multidisciplinary Approach to Fatigue
- Neoadjuvant Chemotherapy With or Without Second-Look Surgery Followed by Radiation Therapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Intracranial Germ Cell Tumors
- Nivolumab in Platinum Recurrent or Refractory Metastatic Germ Cell Tumors
- Observation and/or Combination Chemotherapy After Surgery or Biopsy in Treating Young Patients With Extracranial Germ Cell Tumors
- Paclitaxel, Ifosfamide and Cisplatin (TIP) Versus Bleomycin, Etoposide and Cisplatin (BEP) for Patients With Previously Untreated Intermediate- and Poor-risk Germ Cell Tumors
- Pazopanib in Advanced and Cisplatin-resistant Germ Cell Tumors
- Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
- Phase II Study of Cisplatin Plus Epirubicin Salvage Chemo in Refractory Germ Cell Tumors
- Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell Tumors
- Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy
- Rolapitant Plus Olanzapine in Multiday Cisplatin Chemotherapy
- Role of Axumin PET Scan in Germ Cell Tumor
- Salvage Chemotherapy for Poor Prognosis Germ Cell Tumors
- Simvastatin With Topotecan and Cyclophosphamide in Relapsed and/or Refractory Pediatric Solid and CNS Tumors
- Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
- Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors
- Study Evaluating the Impact of Short Message Service on Compliance With Surveillance of Patients With Germ-cell Tumors
- Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
- Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors
- Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
- Study of the Hypomethylating Drug Guadecitabine (SGI-110) Plus Cisplatin in Relapsed Refractory Germ Cell Tumors
- Studying Biomarkers in Samples From Younger Patients With Malignant Germ Cell Tumor Progression
- Studying Genes in Samples From Younger Patients With Ovarian or Testicular Sex Cord Stromal Tumors
- Symptom Management for YA Cancer Survivors
- Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors
- Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors
- Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors
- Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors
- Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
- Treatment Outcome and Quality of Life in Patients With Pediatric Extra-Cranial Germ Cell Tumors Previously Treated on Clinical Trial CCLG-GC-1979-01 or CCLG-GC-1989-01
- Trial of Gemcitabine, Cisplatin, and Ifosfamide in Patients With Relapsed Non-Seminomatous Germ-Cell Tumors
- Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies